期刊文献+

游离三碘甲状腺原氨酸(FT3)时间分辨荧光免疫分析试剂盒的研制 被引量:2

Development of the time-resolved fluoroimmunoassay kit for detecting FT3
下载PDF
导出
摘要 目的研制一种游离三碘甲状腺原氨酸(free triiodothyronine,FT3)时间分辨荧光免疫分析(time-resolved fuoroimmunoassay,TRFIA)试剂盒。方法采用直接竞争法建立游离三碘甲状腺原氨酸(FT3)检测TRFIA试剂盒(固相包被T3-复合物,与样本中的FT3竞争结合DTTA-Eu3+标记的T3单克隆抗体),并对试剂盒各项指标进行评价。结果该试剂盒的有效检测浓度范围为1.5~70 pmol/L,分析灵敏度为不高于0.7 pmol/L,批内、批间的不精密度分别不高于8.2%与10.5%。与T4、FT4、反T3、反T4交叉反应率分别为:<0.01%、0.11%、<0.01%、<0.01%。稳定性试验表明试剂可以在2~8℃稳定一年,37℃稳定7d。用该试剂盒对500份正常人血清标本进行测试,统计该试剂盒的正常参考值范围是3.2~6.5 pmol/L。156份血清标本用本试剂盒与国外某知名品牌化学发光法试剂盒同时检测,其相关系数为0.992。结论试剂盒各项指标均达到临床检测要求,可考虑作为国外化学发光法同类产品试剂盒的替代产品。 Objective To develop a kit for the detection of human free triiodothyronine(FT3) in serum by time-resolved fuoroimmunoassay(TRFIA).Methods The TRFIA FT3 kit was established by direct competitive method(solid-phase was coated with T3 complex,and competitively binded to T3 monoclonal antibody labeled DTTA-Eu3+with FT3).And the performance of the kit was evaluated.Results The effective working range of the kit was 1.5~70 pmol/L and the analytical sensitivity was not higher than 0.7 pmol/L.The intra-assay and inter-assay coeffcients of variation were not higher than 8.2% and 10.5%,respectively.The percentage of cross reactivity with T4,FT4,rT3,rT4 were 0.01%,0.11%,0.01% and 0.01%,respectively.The TRFIA FT3 reagents can be stored at 2℃ ~8℃ for one year and at 37℃ for 7 days.The cutoff value for TRFIA FT3 kit in healthy subjects was 3.2 pmol/L^6.5 pmol/L,in according to 500 cases of health sample serum with this kit.The correlation coeffcient of blood samples detection results(n=156) between home-made and CLIA kit of one well-known foreign brands was 0.992.Conclusion FT3 TRFIA kit was a valuable diagnostic kit for clinical application with better sensitivity,specifcity,and accuracy.
出处 《分子诊断与治疗杂志》 2013年第5期328-332,共5页 Journal of Molecular Diagnostics and Therapy
关键词 游离三碘甲状腺原氨酸 时间分辨荧光免疫分析 甲状腺功能 Free triiodothyronine Time-resolved fuoroimmunoassay Thyroid function
  • 相关文献

参考文献11

  • 1Potlukova E, Jiskra J, Limanova Z, et al. Autoantibodies against complement Clq correlate with the thyroid function in patients with autoimmune thyroid disease[J]. Clin Exp Immunol, 2008,153(1): 96-101.
  • 2Hollowell J G, Staehling N W, Flanders W D, et al. Serum TSH, T( 4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES ill )[J]. J Clin Endocrinol Metab, 2002, 87(2): 489-499.
  • 3Laurberg P, Bournaud C, Karmisholt J, et al. Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy[J]. Eur J Endocrinol, 2009, 160(1): 1-8.
  • 4Umar H, Muallima N, Adam J M, et al. Hashimoto's thyroiditis following Graves's disease[J]. Acta Med Indones, 2010, 42(1): 31-45.
  • 5Kim B J, Kim T Y, Koh J M, et al. Relationship between serum free T4 (FT4) levels and metabolic syndrome (MS) and its components in healthy euthyroid subjects[J]. Clin Endocrinol(Oxf), 2009, 70(1): 152-160.
  • 6Gardufio-Garcial J, Alvirde-Garcia U, Lopez-Carrasco G, et a1. TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects[J]. Euro J Endocrinol, 2010, 163(2): 273-278.
  • 7Lambadiari V, Mitrou P, Maratou E, et al. Thyroid hormones are positively associated with insulin resistance early in the development of type 2 diabetes[J]. Endocrine, 2011, 39(1): 28-32.
  • 8Kadiyala R, Peter R, Okosieme 0 E. Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies[J]. IntJ Clin Pract, 2010, 64(8): 1130-1139.
  • 9Iglesias P, Diez J J. Thyroid dysfunction and kidney disease[J]. Eur J Endocrinol, 2009,160(4): 503-515.
  • 10Wrede C E. Endocrine regulation in critically ill patients[J]. Dtsch Med Wochenschr, 2010, 135(14): 712-715.

二级参考文献3

共引文献1

同被引文献33

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部